Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...

For a few individuals, scientists found genetic material from cancerous tumors in blood samples taken years before they were ...

Researchers at Uppsala University have identified a promising therapeutic approach for the challenging blood cancer multiple ...

The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...

Most people think of vaccines as being "preventive," and taken to "prevent or lessen the impact of certain infectious ...

Dr. Zhaoming Wang discussed how childhood cancer treatments can speed up biological aging and impact survivors’ health long ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment, the company said on Wednesday.

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune system to destroy tumors. But for some people, they come at a high cost. A rare ...